biomarkers, tumor

Development of ⁸⁹Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration
Arjan Kol, Xiaoyu Fan, Marta A. Wazynska, Sander M.J. van Duijnhoven, Danique Giesen, Annechien Plat, Hans Van Eenennaam, Philip H. Elsinga, Hans W. Nijman, Marco de Bruyn

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e004877; DOI: 10.1136/jitc-2022-004877
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma
Nikhil I Khushalani, Melinda Vassallo, Judith D Goldberg, Zeynep Eroglu, Younchul Kim, Biwei Cao, Robert Ferguson, Kelsey R Monson, Tomas Kirchhoff, Carol M Amato, Paulo Burke, Ann Strange, Emily Monk, Geoffrey Thomas Gibney, Ragini Kudchadkar, Joseph Markowitz, Andrew S Brohl, Anna Pavlick, Alison Richards, David M Woods, Jeffrey Weber

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005684; DOI: 10.1136/jitc-2022-005684
Imaging endpoints for clinical trial use: a RECIST perspective
Saskia Litière, Jan Bogaerts

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005092; DOI: 10.1136/jitc-2022-005092
Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions
Ziena Abdulrahman, Natasja Hendriks, Arnold J Kruse, Antonios Somarakis, Anna J M van de Sande, Heleen J van Beekhuizen, Jurgen M J Piek, Noel F C C de Miranda, Loes F S Kooreman, Brigitte F M Slangen, Sjoerd H van der Burg, Peggy J de Vos van Steenwijk, Edith M G van Esch

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005288; DOI: 10.1136/jitc-2022-005288
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors
Marina Natoli, Klas Hatje, Pratiksha Gulati, Fabian Junker, Petra Herzig, Zhiwen Jiang, Iakov I Davydov, Markus Germann, Marta Trüb, Daniel Marbach, Adrian Zwick, Patrick Weber, Stefan Seeber, Mark Wiese, Didier Lardinois, Viola Heinzelmann-Schwarz, Robert Rosenberg, Lothar Tietze, Kirsten D Mertz, Pablo Umaña, Christian Klein, Laura Codarri-Deak, Henry Kao, Alfred Zippelius

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005548; DOI: 10.1136/jitc-2022-005548
Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)
Marie Wislez, Julien Mazieres, Armelle Lavole, Gérard Zalcman, Olivier Carre, Thomas Egenod, Raffaele Caliandro, Catherine Dubos-Arvis, Gaelle Jeannin, Olivier Molinier, Marie-Ange Massiani, Alexandra Langlais, Franck Morin, Francoise Le Pimpec Barthes, Laurent Brouchet, Jalal Assouad, Bernard Milleron, Diane Damotte, Martine Antoine, Virginie Westeel

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005636; DOI: 10.1136/jitc-2022-005636
Efficacy of cetuximab plus PD-1 inhibitor differs by HPV status in head and neck squamous cell carcinoma: a systematic review and meta-analysis
Siqi Zhang, Mengge Zheng, Deheng Nie, Lili Xu, Huimin Tian, Mengmeng Wang, Wenjia Liu, Zhenbang Feng, Fujun Han

Journal for ImmunoTherapy of Cancer Oct 2022, 10 (10) e005158; DOI: 10.1136/jitc-2022-005158
T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer
Huanhe Ni, Huanling Zhang, Lin Li, He Huang, Hui Guo, Lin Zhang, Chunwei Li, Jing-Xiao Xu, Cai-Ping Nie, Kui Li, Xiaoshi Zhang, Xiaojun Xia, Jiang Li

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e005151; DOI: 10.1136/jitc-2022-005151
N-cadherin protects oral cancer cells from NK cell killing in the circulation by inducing NK cell functional exhaustion via the KLRG1 receptor
Chao Lou, Kailiu Wu, Jianbo Shi, Zhenlin Dai, Qin Xu

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e005061; DOI: 10.1136/jitc-2022-005061
Label-free metabolic imaging for sensitive and robust monitoring of anti-CD47 immunotherapy response in triple-negative breast cancer
Minfeng Yang, Arpan Mahanty, Chunjing Jin, Alex Ngai Nick Wong, Jung Sun Yoo

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e005199; DOI: 10.1136/jitc-2022-005199

Main menu

biomarkers, tumor

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

biomarkers, tumor

Pages